If people are complaining about 'only' 5% QoQ revenue growth, I'd point them to two things
1. The historical ARR revenue growth since Jun-21 which today's result is in line with.
2. The impact that 5% of revenue growth and the continued cost control (that no doubt saved this company from $4 a few months back) had on EBITDA growth (which is 27% QoQ and record).
Could be considered disappointing but not sure how it justifies a ~20% drop in SP.
- Forums
- ASX - By Stock
- MP1
- Ann: 1Q FY24 Investor Presentation
Ann: 1Q FY24 Investor Presentation, page-12
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
NEWS
Biotech innovator secures $5.5M R&D tax incentive refund – major boost for cutting-edge programs
NEWS
Exceptional lithium assays uncovered at Falcon Lake – expanding mineralisation, big potential ahead
Add MP1 (ASX) to my watchlist
|
|||||
Last
$7.78 |
Change
0.270(3.60%) |
Mkt cap ! $1.245B |
Open | High | Low | Value | Volume |
$7.65 | $7.85 | $7.56 | $7.875M | 1.017M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | $7.77 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$7.80 | 4296 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 7.770 |
1 | 1028 | 7.760 |
1 | 800 | 7.730 |
3 | 25768 | 7.720 |
2 | 58375 | 7.700 |
Price($) | Vol. | No. |
---|---|---|
7.800 | 4296 | 3 |
7.830 | 100 | 1 |
7.840 | 15775 | 2 |
7.850 | 25573 | 4 |
7.860 | 5775 | 1 |
Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
Featured News
MP1 (ASX) Chart |